Wockhardt gets Ireland authority nod

| Updated on January 13, 2018

The Health Products Regulatory Authority of Ireland has inspected Wockhardt’s Shendra, Aurangabad, facility, and recommended the renewal of certificate. Earlier this month, the USFDA had issued a warning letter to Morton Grove Pharmaceuticals Inc, USA, a step-down subsidiary of Wockhardt. This would mean that the “current portfolio of the company will continue to be made available” in the US but “new approvals will be withheld”, it had said then.

Published on March 07, 2017

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor